Page last updated: 2024-11-05

ammelide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ammelide, a triazine derivative, is a key intermediate in the synthesis of melamine, a valuable industrial chemical. It is typically produced through the hydrolysis of melamine. Its unique chemical structure and reactivity have attracted research interest for various applications. Ammelide has potential applications in areas such as flame retardants, polymers, and pharmaceuticals due to its nitrogen-rich nature and ability to form hydrogen bonds. The study of ammelide helps in understanding the reactivity and properties of triazines and their potential applications in various fields.'

ammelide: structure given in first source; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12584
CHEBI ID28134
SCHEMBL ID36691
MeSH IDM0184118

Synonyms (46)

Synonym
nsc8146
nsc-8146
CHEBI:28134
6-amino-1,3,5-triazine-2,4(1h,3h)-dione
1,3,5-triazine-2,4(1h,3h)-dione, 6-amino-
ammedlide
6-amino-1,3,5-triazine-2,4-diol
ammelide
2,4-dihydroxy-6-amino-1,3,5-triazine
C08734
645-93-2
dihydro-6-imino-1,3,5-triazine-2,4(1h,3h)-dione
cyanuric acid monoamide
melanuric acid
A0645
6-amino-1h-1,3,5-triazine-2,4-dione
A834821
6-azanyl-1h-1,3,5-triazine-2,4-dione
6-amino-s-triazine-2,4-diol
AKOS006222979
j604qc4098 ,
einecs 211-456-7
ai3-61038
unii-j604qc4098
nsc 8146
FT-0622302
6-amino-2,4-dihydroxy-1,3,5-triazine
AKOS022175465
SCHEMBL36691
167613-80-1
DTXSID10214757 ,
6-amino-1,3,5-triazine-2,4(1h,3h)-dione, aldrichcpr
mfcd00049046
ammelide, analytical standard
AS-60764
T71177
terbutylazine metabolite mt24
Q4747226
STL186172
terbuthylazine-tp mt24 (lm1)
SB73399
1,3,5-triazine-2,4-diol,6-amino-(9ci)
ammelide; 98%
EN300-1461831
cid 5281299
Z1203578012

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
dihydroxy-1,3,5-triazine
monoamino-1,3,5-triazine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.00)18.2507
2000's5 (25.00)29.6817
2010's13 (65.00)24.3611
2020's1 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.09 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index79.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]